Jeff Jaquet, Clinical Project Management Director, brings more than 17 years of clinical project management experience to his role of operational oversight director in the Central Nervous System (CNS) team at IQVIA Biotech. Jeff focuses on CNS projects, managing end-to-end study services for a variety of indications including autism, multiple sclerosis, acute ischemic stroke, and rare disorders. Working closely with multiple teams, he helps ensure all study management and project deliverables are provided to customers with high quality and within the designated timeline and budget. As part of the dedicated CNS team, Jeff says he is inspired by the innovation delivered by biotech companies for patients affected by diseases of the brain and central nervous system.

Jeff refers to his work in clinical project management for multiple studies as an intricate web, where he is responsible for the high-level view and keeping various project managers and functional leads aligned, ensuring all the moving parts of each project are on track for customers. This also means he offers team members timely consultative guidance on issue resolution as well as mentoring employees on project planning and review, risk management and problem solving to maintain consistency in process practices and technology use across global teams. Recognizing the importance of communication with customers, he also enjoys building and maintaining customer relationships and being their “point person” as projects evolve and potentially grow into studies.

It is the close and diverse working relationships with internal team members and customers that initially drew Jeff to the project management aspects of clinical research. Jeff notes he finds it exciting to find ways to align team members, collaborate across regions, functions and more to meet customer needs quickly and with quality. His interest in clinical project management stems from his previous work in the industry starting as a clinical research associate with global pharmaceutical companies AstraZeneca and Sanofi Aventis. Jeff holds a master’s degree in Medical Biology from the University of Leiden in the Netherlands. Jeff’s work combines his scientific expertise with his interest in working side-by-side with study teams to improve outcomes for those living with CNS conditions.

Seeing the real-time growth, team spirit and focus of the IQVIA Biotech CNS team, Jeff is motivated to help build the team further and assure biotech customers that critical CNS projects are running efficiently and on time. The foundation of his commitment is built on a shared vision with clients on improving CNS treatment options. Patient centricity remains a driving force in his day-to-day activities, and Jeff asserts he is extremely proud to partner alongside biotech companies for CNS clinical research.

Working with an experienced global project management team for your CNS clinical development program(s) can be critical to your trial’s success. Contact us to learn how our dedicated CNS Project Management unit can support your study.